Drugs for Gastrointestinal Diseases Practice Questions

Q: Which of the following is beneficial in NSAID-induced gastric ulcer?

PGE1 agonist. The correct answer is **A. PGE1 agonist**. **Mechanism of Action:** NSAIDs induce gastric ulcers primarily by inhibiting the enzyme **Cyclooxygenase-1 (COX-1)**, which leads to a deficiency in endogenous prostaglandins (PGE2 and PGI2) in the gastric mucosa [2], [3]. These prostaglandins are essential for "cytoprotection" as they decrease gastric acid secretion, increase bicarbonate production, and enhance mucosal blood flow [4]. **Misoprostol**, a synthetic **PGE1 analog (agonist)**, acts as a replacement for these lost prostaglandins [1]. It binds to EP3 receptors on parietal cells to inhibit cAMP-mediated acid secretion, making it the drug of choice for the prevention of NSAID-induced ulcers [1]. **Analysis of Incorrect Options:** * **B. PGE2 agonist:** While endogenous PGE2 is naturally cytoprotective [2], the specific pharmacological agent used in clinical practice for NSAID-induced ulcer prophylaxis is a PGE1 derivative (Misoprostol) [1]. PGE2 analogs (like Dinoprostone) are primarily used in obstetrics for cervical ripening. * **C & D. PGD and PGF2 agonists:** These prostaglandins do not play a significant role in gastric mucosal protection. PGF2α (e.g., Carboprost, Latanoprost) is involved in uterine contraction and intraocular pressure regulation, while PGD2 is primarily involved in allergic responses and sleep regulation. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** While Misoprostol is the specific physiological antagonist for NSAID-induced ulcers, **Proton Pump Inhibitors (PPIs)** are more commonly used in clinical practice due to better tolerability [2]. * **Contraindication:** Misoprostol is strictly **contraindicated in pregnancy** (Category X) because it causes uterine contractions and can lead to abortion. * **Side Effects:** The most common side effect of Misoprostol is **diarrhea** and abdominal cramps.

Q: Which one of the following drugs exacerbates reflux esophagitis?

Theophylline. **Explanation:** The primary pathophysiological mechanism behind Gastroesophageal Reflux Disease (GERD) or reflux esophagitis is the relaxation of the **Lower Esophageal Sphincter (LES)** [1][3]. Any drug that decreases LES tone will exacerbate the condition. **Why Theophylline is correct:** Theophylline is a methylxanthine used in asthma and COPD [5]. It acts by inhibiting the enzyme **phosphodiesterase (PDE)**, leading to increased levels of intracellular **cAMP** [4]. In smooth muscles, elevated cAMP causes relaxation. When this occurs at the LES, it reduces the pressure barrier between the stomach and esophagus, allowing acidic gastric contents to reflux upwards, thereby exacerbating esophagitis [1]. **Why the other options are incorrect:** * **Cisapride:** This is a prokinetic agent that acts as a 5-HT4 receptor agonist [2]. It **increases** LES tone and enhances gastric emptying, making it a drug used to *treat* GERD, not exacerbate it. However, it is largely restricted due to the risk of **QT interval prolongation** [2]. * **Metoclopramide:** A D2 receptor antagonist with prokinetic properties. Like cisapride, it **increases** LES pressure and promotes upper GI motility, thus helping to *prevent* reflux. * **Chlorpropamide:** This is a first-generation sulfonylurea used in Diabetes Mellitus. It has no significant pharmacological effect on LES tone or esophageal motility. **High-Yield Clinical Pearls for NEET-PG:** * **Other drugs that exacerbate GERD:** Anticholinergics, Nitrates, Calcium Channel Blockers (CCBs), Progesterone, and Beta-agonists (all relax smooth muscle). * **Prokinetic of choice:** While Cisapride is effective, it is largely restricted due to the risk of **QT interval prolongation** (Torsades de pointes) [2]. * **Theophylline Toxicity:** Remember that Theophylline has a narrow therapeutic index; its metabolism is inhibited by Cimetidine and Erythromycin, increasing the risk of toxicity.

Q: Which of the following drugs does NOT cause peptic ulcer?

Propylthiouracil. **Explanation:** The correct answer is **Propylthiouracil (PTU)**. PTU is an antithyroid drug used in the management of hyperthyroidism and Graves' disease. Its primary mechanism involves inhibiting the enzyme thyroid peroxidase and blocking the peripheral conversion of T4 to T3 [1]. It is **not** associated with gastric mucosal injury or peptic ulcer disease (PUD). Its major side effects include agranulocytosis, hepatotoxicity, and ANCA-associated vasculitis [3]. **Analysis of Incorrect Options:** * **NSAIDs (e.g., Aspirin, Ibuprofen):** These are the most common pharmacological cause of PUD. They inhibit the COX-1 enzyme, leading to decreased synthesis of protective prostaglandins ($PGE_2$ and $PGI_2$), which are essential for maintaining the gastric mucosal barrier and bicarbonate secretion [2]. * **Clopidogrel:** While not directly ulcerogenic like NSAIDs, this antiplatelet agent impairs the healing of pre-existing gastric erosions by inhibiting platelet-derived growth factors (PDGF) and vascular endothelial growth factors (VEGF) required for mucosal repair. This significantly increases the risk of upper GI bleeding. * **Mycophenolate Mofetil (MMF):** This immunosuppressant is notorious for GI toxicity. It causes direct mucosal damage and inhibits the proliferation of rapidly dividing enterocytes, frequently leading to gastritis, erosions, and "MMF-induced colitis." **High-Yield Clinical Pearls for NEET-PG:** * **Steroids alone** have a low risk of causing ulcers, but when combined with **NSAIDs**, the risk of PUD increases exponentially (synergistic effect). * **Bisphosphonates** (e.g., Alendronate) and **Potassium chloride tablets** are other common causes of drug-induced esophageal and gastric ulcers. * **Prophylaxis:** For patients on long-term NSAIDs with high ulcer risk, **Misoprostol** ($PGE_1$ analogue) or **PPIs** are the drugs of choice for prevention.

Q: What is the drug of choice for the treatment of peptic ulcer caused due to chronic use of NSAIDs?

Esomeprazole. **Explanation:** The treatment and prevention of NSAID-induced peptic ulcers depend on whether the NSAID can be discontinued. In clinical practice, **Proton Pump Inhibitors (PPIs)** like **Esomeprazole** are the **drug of choice** for both the healing and prevention of NSAID-induced ulcers. They are superior to H2 blockers and mucosal protective agents because they provide rapid symptomatic relief and faster ulcer healing by maintaining a gastric pH > 4. **Analysis of Options:** * **Esomeprazole (Option D):** As a PPI, it irreversibly inhibits the $H^+/K^+$ ATPase pump. It is more effective than Misoprostol in healing existing ulcers and is better tolerated by patients, making it the first-line recommendation. * **Misoprostol (Option C):** This is a $PGE_1$ analogue. While it is the **specific** drug for preventing NSAID-induced ulcers (by replacing the prostaglandins inhibited by NSAIDs), it is **not** the drug of choice for treatment due to frequent side effects like abdominal cramps and diarrhea. * **Loxatidine (Option B):** An $H_2$ receptor antagonist. While effective for simple peptic ulcers, $H_2$ blockers are less effective than PPIs for NSAID-induced ulcers, especially if the patient must continue taking the NSAID. * **Pirenzepine (Option A):** An $M_1$ selective anticholinergic. It is rarely used today due to low efficacy and significant side effects (dry mouth, blurred vision) compared to modern acid suppressants. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for Treatment:** PPIs (e.g., Esomeprazole, Omeprazole). * **Most Specific Drug for Prevention:** Misoprostol (but PPIs are preferred clinically due to better compliance). * **Mechanism of NSAID Ulcers:** Inhibition of COX-1 leads to decreased synthesis of protective prostaglandins ($PGE_2$ and $PGI_2$). * **Contraindication:** Misoprostol is strictly contraindicated in pregnancy as it can cause uterine contractions and abortion.

Q: Which derivative of morphine is used for the treatment of diarrhea?

Diphenoxylate. **Explanation:** **Diphenoxylate** is the correct answer because it is a synthetic opioid derivative specifically designed for its anti-diarrheal properties. It acts primarily on the **$\mu$-opioid receptors** in the gastrointestinal tract, decreasing intestinal motility and increasing the transit time of luminal contents. This allows for greater water absorption, thereby thickening the stool. * **Why Diphenoxylate?** Unlike morphine, diphenoxylate has poor CNS penetration at therapeutic doses, making it less likely to cause analgesia or euphoria. It is commonly formulated with a sub-therapeutic dose of **Atropine** (Lomotil) to discourage abuse, as higher doses would cause unpleasant anticholinergic side effects. **Analysis of Incorrect Options:** * **Oxymorphine:** A potent semi-synthetic opioid analgesic. While it causes constipation as a side effect, it is not used clinically to treat diarrhea due to its high addictive potential and CNS effects. * **Pethidine (Meperidine):** A phenylpiperidine derivative used primarily for analgesia (especially in labor and biliary colic). It is not indicated for diarrhea. * **Codeine:** While codeine is an opioid that causes significant constipation, its primary clinical uses are as an analgesic and an antitussive (cough suppressant). **High-Yield Clinical Pearls for NEET-PG:** * **Loperamide** is another morphine derivative used for diarrhea. It is preferred over diphenoxylate because it does not cross the blood-brain barrier at all (due to P-glycoprotein efflux), resulting in **zero abuse potential**. * **Mechanism:** Opioids inhibit the release of Acetylcholine from the myenteric plexus, leading to decreased peristalsis. * **Contraindication:** Anti-diarrheals should be avoided in **infectious diarrhea** (e.g., *Salmonella*, *Shigella*) as they may delay the clearance of toxins and lead to toxic megacolon.

Q: Which 5-HT receptor subtype acts as the primary emesis receptor?

5HT3. **Explanation:** The correct answer is **5-HT3**. **Why 5-HT3 is the primary emesis receptor:** The 5-HT3 receptor is a ligand-gated ion channel located in three critical areas involved in the vomiting reflex: the **Chemoreceptor Trigger Zone (CTZ)** in the area postrema, the **Nucleus Tractus Solitarius (NTS)**, and on **vagal afferents** in the gastrointestinal tract. When cytotoxic drugs (chemotherapy) damage enterochromaffin cells in the gut, they release massive amounts of serotonin. This serotonin stimulates 5-HT3 receptors on vagal nerves, sending signals to the brain's vomiting center. Consequently, 5-HT3 antagonists (e.g., **Ondansetron**) are the first-line drugs for preventing Chemotherapy-Induced Nausea and Vomiting (CINV). **Why other options are incorrect:** * **5-HT1:** These receptors (specifically 5-HT1A/1B/1D) are primarily involved in neurotransmission in the CNS and vasoconstriction of cranial blood vessels. They are the targets for **Triptans** used in migraine, not emesis. * **5-HT2:** These receptors are involved in platelet aggregation, smooth muscle contraction, and hallucinations (LSD target). They do not play a significant role in the emetic pathway. * **5-HT4:** These receptors are located in the GI tract and facilitate the release of acetylcholine. 5-HT4 **agonists** (e.g., Prucalopride, Tegaserod) act as **prokinetic agents** to increase gut motility, rather than acting as primary emetic triggers. **High-Yield Clinical Pearls for NEET-PG:** * **Ondansetron** is the prototype 5-HT3 antagonist. Its most common side effects are **headache** and **constipation**. * A significant ECG side effect of 5-HT3 antagonists is **QT interval prolongation**. * For highly emetogenic chemotherapy, 5-HT3 antagonists are often combined with **Dexamethasone** and **Aprepitant** (NK1 receptor antagonist) for synergistic effect.

Q: Granisetron has antiemetic properties because of which of the following actions?

Serotonin receptor-blocking action. **Explanation:** **Granisetron** is a potent, highly selective **5-HT₃ (Serotonin) receptor antagonist**. The correct answer is **D** because its antiemetic mechanism involves blocking serotonin receptors both peripherally (on vagal nerve terminals in the gastrointestinal tract) and centrally (in the Chemoreceptor Trigger Zone - CTZ). When cytotoxic drugs or radiation damage the intestinal mucosa, enterochromaffin cells release serotonin. This serotonin stimulates 5-HT₃ receptors, sending emetic signals to the brain. By blocking these receptors, Granisetron effectively prevents nausea and vomiting, particularly in the context of chemotherapy. **Analysis of Incorrect Options:** * **Option A (Dopaminergic blocking):** This is the mechanism of drugs like **Metoclopramide** and **Domperidone** (D₂ blockers). While effective antiemetics, Granisetron does not act on dopamine receptors. * **Options B & C (GABA actions):** GABAergic pathways are generally not the primary target for standard antiemetics. Benzodiazepines (like Lorazepam) may be used as adjuncts for *anticipatory* vomiting due to their sedative/anxiolytic effects, but Granisetron has no GABA-mimetic or inhibitory activity. **High-Yield Clinical Pearls for NEET-PG:** * **Drug Class:** Granisetron belongs to the "-setron" family (Ondansetron, Palonosetron, Dolasetron). * **DOC:** 5-HT₃ antagonists are the **Drug of Choice** for Chemotherapy-Induced Nausea and Vomiting (CINV) and Post-Operative Nausea and Vomiting (PONV). * **Side Effects:** The most common side effects are **headache** and **constipation**. * **ECG Changes:** They can cause **QT interval prolongation** (caution in patients with cardiac arrhythmias). * **Palonosetron** is the longest-acting drug in this class.

Q: What is the mechanism of action of cisapride?

Agonism of 5HT4 receptors. **Explanation:** **Mechanism of the Correct Answer (D):** Cisapride is a **prokinetic agent** that primarily acts as a **selective 5-HT4 receptor agonist**. These receptors are located on the presynaptic terminals of enteric cholinergic neurons. Activation of 5-HT4 receptors stimulates the release of **Acetylcholine (ACh)** at the myenteric plexus (Auerbach's plexus). Increased ACh levels enhance gastrointestinal motility and increase Lower Esophageal Sphincter (LES) tone without stimulating gastric acid secretion. **Analysis of Incorrect Options:** * **Option A (D2 Inhibition):** This is the mechanism of **Metoclopramide** and **Domperidone**. While Metoclopramide also has 5-HT4 agonist properties, Cisapride is distinct because it lacks D2 receptor antagonism, meaning it does not cause extrapyramidal side effects or hyperprolactinemia. * **Option B (5-HT3 Antagonism):** This is the mechanism of **Ondansetron**, used primarily as an antiemetic. While Cisapride has weak 5-HT3 antagonistic properties, its prokinetic effect is strictly due to 5-HT4 agonism. * **Option C (5-HT4 Antagonism):** This would inhibit GI motility. An example of a 5-HT4 antagonist is **Prucalopride** (though it is actually a succinate agonist used for constipation; true antagonists are rarely used clinically). **High-Yield Clinical Pearls for NEET-PG:** * **Cardiac Toxicity:** Cisapride is notorious for causing **QT interval prolongation** and **Torsades de Pointes** by blocking HERG K+ channels. This led to its withdrawal or restricted use in many countries. * **Drug Interactions:** It is metabolized by **CYP3A4**. Co-administration with CYP3A4 inhibitors (e.g., Ketoconazole, Erythromycin) increases its plasma levels, significantly raising the risk of fatal arrhythmias. * **Comparison:** Unlike Metoclopramide, Cisapride acts throughout the GI tract, including the colon.

Q: What is the primary action of sucralfate?

Is ulcer protective. **Explanation:** **Sucralfate** is a complex salt of sucrose octasulfate and aluminum hydroxide. Its primary mechanism of action is **cytoprotection** rather than altering gastric pH. 1. **Why Option C is Correct:** In an acidic environment (pH < 4), sucralfate undergoes polymerization to form a sticky, viscid gel. This paste has a strong negative charge and binds to positively charged proteins (albumin, fibrinogen) exposed in the **ulcer base**. It creates a physical barrier (a "chemical bandage") that protects the ulcer from acid, pepsin, and bile salts, allowing the mucosa to heal. It also stimulates local prostaglandin production and binds to fibroblast growth factors (FGF), further aiding mucosal repair. 2. **Why Other Options are Incorrect:** * **Option A:** Sucralfate does not inhibit the proton pump or H2 receptors; therefore, it does not reduce acid secretion. * **Option B:** While it contains aluminum hydroxide, its acid-neutralizing capacity is clinically insignificant at therapeutic doses. * **Option C:** It has no intrinsic antimicrobial activity against *H. pylori*. **High-Yield Clinical Pearls for NEET-PG:** * **Activation Requirement:** It requires an **acidic medium** for activation. Therefore, it should **not** be given with antacids, H2 blockers, or PPIs (which raise gastric pH). * **Administration:** It should be taken on an empty stomach, 1 hour before meals. * **Side Effects:** The most common side effect is **constipation** (due to the aluminum content). * **Drug Interactions:** It can adsorb other drugs (e.g., phenytoin, digoxin, tetracycline, ciprofloxacin), reducing their absorption. Maintain a 2-hour gap. * **Indication:** Primarily used in duodenal ulcers and for prophylaxis of stress ulcers in critically ill patients.

Q: Triple therapy for H. pylori includes all EXCEPT?

Sucralfate. **Explanation:** The standard **Triple Therapy** for *Helicobacter pylori* eradication is the first-line treatment regimen used to manage peptic ulcer disease and prevent recurrence. It typically consists of a Proton Pump Inhibitor (PPI) and two antibiotics. **Why Sucralfate is the correct answer:** Sucralfate is a mucosal protective agent that forms a physical barrier (paste) over the ulcer base. While it aids in ulcer healing, it has **no antimicrobial activity** against *H. pylori*. Therefore, it is not a component of the standard triple therapy regimen. **Analysis of Incorrect Options:** * **Omeprazole (Option A):** A PPI is a core component of triple therapy. It increases gastric pH, which not only promotes healing but also enhances the stability and efficacy of the co-administered antibiotics. * **Clarithromycin (Option B):** This is a macrolide antibiotic and the most potent agent against *H. pylori* in the regimen. * **Metronidazole (Option C):** This is an imidazole antibiotic often used as an alternative to Amoxicillin in patients with penicillin allergy, or as part of the standard triple therapy in certain geographical regions. **NEET-PG High-Yield Pearls:** 1. **Standard Triple Therapy (OCM/OCA):** Omeprazole + Clarithromycin + Metronidazole (or Amoxicillin) for 10–14 days. 2. **Bismuth Quadruple Therapy:** Used if triple therapy fails or in areas of high clarithromycin resistance. It includes **PPI + Bismuth subsalicylate + Metronidazole + Tetracycline**. 3. **Pylera:** A 3-in-1 capsule containing Bismuth, Metronidazole, and Tetracycline. 4. **Sequential Therapy:** 5 days of PPI + Amoxicillin, followed by 5 days of PPI + Clarithromycin + Tinidazole.

Question 1

Which of the following is beneficial in NSAID-induced gastric ulcer?

Accepted Answer

PGE1 agonist

Answer

PGE2 agonist

Answer

PGD agonist

Answer

PGF2 agonist

Question 2

Which one of the following drugs exacerbates reflux esophagitis?

Accepted Answer

Theophylline

Answer

Cisapride

Answer

Chlorpropamide

Answer

Metoclopramide

Question 3

Which of the following drugs does NOT cause peptic ulcer?

Accepted Answer

Propylthiouracil

Answer

Clopidogrel

Answer

NSAID

Answer

Mycophenolate mofetil

Question 4

What is the drug of choice for the treatment of peptic ulcer caused due to chronic use of NSAIDs?

Accepted Answer

Esomeprazole

Answer

Pirenzepine

Answer

Loxatidine

Answer

Misoprostol

Question 5

Which derivative of morphine is used for the treatment of diarrhea?

Accepted Answer

Diphenoxylate

Answer

Oxymorphine

Answer

Pethidine

Answer

Codeine

Question 6

Which 5-HT receptor subtype acts as the primary emesis receptor?

Accepted Answer

5HT3

Answer

5HT1

Answer

5HT2

Answer

5HT4

Question 7

Granisetron has antiemetic properties because of which of the following actions?

Accepted Answer

Serotonin receptor-blocking action

Answer

Dopaminergic receptor-blocking actions

Answer

Gabamimetic actions

Answer

Gaba-inhibitory actions

Question 8

What is the mechanism of action of cisapride?

Accepted Answer

Agonism of 5HT4 receptors

Answer

Inhibition of D2 receptors

Answer

Antagonism of 5HT3 receptors

Answer

Antagonism of 5HT4 receptors

Question 9

What is the primary action of sucralfate?

Accepted Answer

Is ulcer protective

Answer

Reduces gastric acid secretion

Answer

Neutralizes gastric acid

Answer

Is an anti H. pylori drug

Question 10

Triple therapy for H. pylori includes all EXCEPT?

Accepted Answer

Sucralfate

Answer

Omeprazole

Answer

Clarithromycin

Answer

Metronidazole

Drugs for Gastrointestinal Diseases — MCQs

Drugs for Gastrointestinal Diseases — MCQs

On this page

Practice by Chapter

Want unlimited practice?